ICD-11 · 6C46.2

Stimulant dependence including amphetamines, methamphetamine or methcathinone

Stimulant dependence including amphetamines, methamphetamine or methcathinone is a disorder of regulation of stimulant use arising from repeated or continuous use of stimulants. The characteristic feature is a strong internal drive to use stimulants, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use stimulants. Physiological features of dependence may also be present, including tolerance to the effects of stimulants, withdrawal symptoms following cessation or reduction in use of stimulants, or repeated use of stimulants or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if stimulant use is continuous (daily or almost daily) for at least 3 months.

ICD-11 diagnostic criteria

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Stimulant dependence including amphetamines, methamphetamine or methcathinone are:

Differential diagnosis

When diagnosing Stimulant dependence including amphetamines, methamphetamine or methcathinone, the following ICD-11 disorders should be considered in the differential diagnosis:

Frequently asked questions

How is Stimulant dependence including amphetamines, methamphetamine or methcathinone diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Stimulant dependence including amphetamines, methamphetamine or methcathinone (6C46.2) include: silne pragnienie użycia stymulantów; utrata kontroli nad używaniem; kontynuowanie używania mimo szkód; tolerancja substancji.

What disorders are in the differential diagnosis of Stimulant dependence including amphetamines, methamphetamine or methcathinone?

The differential diagnosis of Stimulant dependence including amphetamines, methamphetamine or methcathinone (6C46.2) includes: Uzależnienie od kokainy (6C45.2), Uzależnienie od syntetycznych katynonów (6C47.2), Epizod szkodliwego używania środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.0), Szkodliwy wzorzec używania środków pobudzających, w tym amfetamin, metamfetaminy lub metylkatynonu (6C46.1), Szkodliwy wzorzec używania środków pobudzających, w tym amfetamin, metamfetaminy lub metylkatynonu, epizodyczny (6C46.10), Szkodliwy wzorzec używania środków pobudzających, w tym amfetamin, metamfetaminy lub metylkatynonu, ciągły (6C46.11), Szkodliwy wzorzec używania środków pobudzających, w tym amfetamin, metamfetaminy i metylkatynonu, nieokreślony (6C46.1Z).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C46.2 – WHO ICD-11

Open in interactive browser →
Source: WHO ICD-11 (chapter 6 – Mental, behavioral and neurodevelopmental disorders). Used under CC BY-ND 3.0 IGO. ICD Diagnostica is not affiliated with or endorsed by WHO. Informational use only – does not replace clinical judgment.